US FDA Expands KASA Platform To Probe API Synthesis, Conduct NDA Quality Reviews

 
• By Bowman Cox
  
pharmaceutical analytics
kasa will enable quicker, more insightful assessments. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance